SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-046399
Filing Date
2022-08-10
Accepted
2022-08-10 16:45:49
Documents
48
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0622_oramedpharm.htm   iXBRL 10-Q 548537
2 CERTIFICATION f10q0622ex31-1_oramedpharm.htm EX-31.1 9420
3 CERTIFICATION f10q0622ex31-2_oramedpharm.htm EX-31.2 9260
4 CERTIFICATION f10q0622ex32-1_oramedpharm.htm EX-32.1 3436
5 CERTIFICATION f10q0622ex32-2_oramedpharm.htm EX-32.2 3229
  Complete submission text file 0001213900-22-046399.txt   3351561

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ormp-20220630.xsd EX-101.SCH 45289
7 XBRL CALCULATION FILE ormp-20220630_cal.xml EX-101.CAL 28871
8 XBRL DEFINITION FILE ormp-20220630_def.xml EX-101.DEF 180398
9 XBRL LABEL FILE ormp-20220630_lab.xml EX-101.LAB 369942
10 XBRL PRESENTATION FILE ormp-20220630_pre.xml EX-101.PRE 184036
42 EXTRACTED XBRL INSTANCE DOCUMENT f10q0622_oramedpharm_htm.xml XML 320045
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35813 | Film No.: 221152412
SIC: 2834 Pharmaceutical Preparations